Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Author's Avatar
Mar 31, 2023

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced full year 2022 results and provided a business update.